IVA期肝细胞癌与v8
| 药物 | 药物名称 | 药物的描述 |
|---|
| 药物 | 药物名称 | 目标 | 类型 |
|---|
| 药物 | 药物名称 | 阶段 | 状态 | 数 |
|---|---|---|---|---|
| DB00062 | 白蛋白人类 | 1 | 招聘 | 1 |
| DB11595 | Atezolizumab | 1 | 招聘 | 1 |
| DB08875 | Cabozantinib | 1 | 招聘 | 1 |
| DB00531 | 环磷酰胺 | 1 | 积极不招聘 | 1 |
| DB00531 | 环磷酰胺 | 1 | 招聘 | 1 |
| DB11714 | Durvalumab | 1 | 招聘 | 1 |
| DB05643 | IRX-2 | 1 | 积极不招聘 | 1 |
| DB09035 | Nivolumab | 1 | 积极不招聘 | 1 |
| DB01229 | 紫杉醇 | 1 | 招聘 | 1 |
| DB09037 | Pembrolizumab | 1 | 招聘 | 1 |
| DB00020 | Sargramostim | 1 | 招聘 | 1 |
| DB11771 | Tremelimumab | 1 | 招聘 | 1 |
| DB00544 | 氟尿嘧啶 | 1 / 2 | 招聘 | 1 |
| DB14986 | Linrodostat | 1 / 2 | 积极不招聘 | 1 |
| DB09035 | Nivolumab | 1 / 2 | 积极不招聘 | 1 |
| DB09035 | Nivolumab | 1 / 2 | 招聘 | 1 |
| DB11595 | Atezolizumab | 2 | 招聘 | 1 |
| DB08875 | Cabozantinib | 2 | 招聘 | 1 |
| DB00958 | 卡铂 | 2 | 积极不招聘 | 1 |
| DB11714 | Durvalumab | 2 | 招聘 | 1 |
| DB06186 | Ipilimumab | 2 | 招聘 | 1 |
| DB09078 | Lenvatinib | 2 | 招聘 | 2 |
| DB09035 | Nivolumab | 2 | 积极不招聘 | 1 |
| DB09035 | Nivolumab | 2 | 招聘 | 1 |
| DB01229 | 紫杉醇 | 2 | 积极不招聘 | 1 |
| DB11759 | Pevonedistat | 2 | 积极不招聘 | 1 |
| DB00398 | 索拉非尼 | 2 | 积极不招聘 | 1 |
| DB11771 | Tremelimumab | 2 | 招聘 | 1 |